References in periodicals archive ?
Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer.
On Wednesday, August 7, Affimed (NASDAQ: AFMD) will release its latest earnings report.
Shares of Affimed (AFMD) plunged in morning trading after the company suspended trials on a cancer drug following the death of a patient.
Hit by a distributor, AFMD, that was going out of business and a reticence among exhibitors to give decent screen space to a non-Disney children's film, "Babel" can be added to a long list of film industry casualties -- at least in France.
Affimed (AFMD), down 27% after suspending a phase 1 trial following the death of a patient...
LOWER: Affirmed (AFMD) down 24.6% after suspending AFM phase 1 trial...
Additionally, the analyst points out that Affimed (AFMD) also has a preclinical BCMA engager AFM26, established proof-of-concept data for CD30 bispecific AFM13, and upcoming proof-of-concept data for CD19 bispecific AFM11.
(AFMD) upgraded to Buy from Hold at Jefferies with analyst Maury Raycroft saying its collaboration with Roche Group's (RHHBY) Genentech to develop and commercialize novel NK cell engagers indicate the intrinsic value in Affimed's platform and approach.
Affimed NV (AFMD), up 165% after announcing that it has entered into a strategic collaboration agreement with Roche's (RHHBY) Genentech to develop and commercialize novel NK cell engager-based immunotherapeutics to treat multiple cancers.
An AFMD (in France) release of a Vertigo Prods./Films Christiani/Orly Films production, with participation of Canal]Plus, CNC.
Affimed (AFMD), down 6.1% after it announced a common stock offering...
An AFMD release (in France) of a Film Par Film/TF1 Films Production production, with participation of Cofimage 8 and TPS Cinema.
Acronyms browser ?
Full browser ?
- AFM file
- AFM in Bio
- AFM in Bio
- AFMC CSO
- AFMC Enterprise Intranet
- AFMC LO
- AFMC LSO